Anne McLeer‐Florin

1.7k total citations
17 papers, 895 citations indexed

About

Anne McLeer‐Florin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Anne McLeer‐Florin has authored 17 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Anne McLeer‐Florin's work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (8 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Anne McLeer‐Florin is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (8 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Anne McLeer‐Florin collaborates with scholars based in France, Italy and Spain. Anne McLeer‐Florin's co-authors include Élisabeth Brambilla, Sylvie Lantuéjoul, Denis Moro‐Sibilot, Florence de Fraipont, Jean Boutonnât, Vincent Peyrot, Christine Lefebvre, Dimitri Salameire, G. Ferretti and M. Duruisseaux and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Anne McLeer‐Florin

17 papers receiving 888 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne McLeer‐Florin France 13 586 420 260 246 143 17 895
Francesca Casaluce Italy 15 462 0.8× 512 1.2× 140 0.5× 326 1.3× 45 0.3× 38 841
Yongping Xu China 13 231 0.4× 289 0.7× 167 0.6× 377 1.5× 70 0.5× 26 800
Maria Anna Bareschino Italy 16 381 0.7× 382 0.9× 95 0.4× 297 1.2× 51 0.4× 27 707
Rama Krishna Kancha India 14 304 0.5× 365 0.9× 150 0.6× 286 1.2× 114 0.8× 37 761
Marcelo Cruz United States 7 286 0.5× 593 1.4× 216 0.8× 300 1.2× 31 0.2× 8 913
Assunta Sgambato Italy 15 416 0.7× 441 1.1× 125 0.5× 293 1.2× 39 0.3× 31 742
Bin-Chi Liao Taiwan 15 561 1.0× 553 1.3× 118 0.5× 217 0.9× 59 0.4× 36 791
Songwen Zhou China 17 280 0.5× 236 0.6× 291 1.1× 425 1.7× 43 0.3× 39 724
Silvia Paola Corona Italy 13 357 0.6× 391 0.9× 152 0.6× 230 0.9× 25 0.2× 43 689
Xiaoran Han China 12 517 0.9× 595 1.4× 155 0.6× 707 2.9× 41 0.3× 22 1.2k

Countries citing papers authored by Anne McLeer‐Florin

Since Specialization
Citations

This map shows the geographic impact of Anne McLeer‐Florin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne McLeer‐Florin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne McLeer‐Florin more than expected).

Fields of papers citing papers by Anne McLeer‐Florin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne McLeer‐Florin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne McLeer‐Florin. The network helps show where Anne McLeer‐Florin may publish in the future.

Co-authorship network of co-authors of Anne McLeer‐Florin

This figure shows the co-authorship network connecting the top 25 collaborators of Anne McLeer‐Florin. A scholar is included among the top collaborators of Anne McLeer‐Florin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne McLeer‐Florin. Anne McLeer‐Florin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Pinsolle, J., Julie Mondet, M. Duruisseaux, et al.. (2019). A Rare Fusion of CLIP1 and ALK in a Case of Non–Small-Cell Lung Cancer With Neuroendocrine Features. Clinical Lung Cancer. 20(5). e535–e540. 3 indexed citations
3.
Devarakonda, Siddhartha, Federico Rotolo, Ming‐Sound Tsao, et al.. (2018). Tumor Mutation Burden as a Biomarker in Resected Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 36(30). 2995–3006. 180 indexed citations
4.
Bailly, Lucie, Laurent Orgéas, Nathalie Henrich Bernardoni, et al.. (2018). 3D multiscale imaging of human vocal folds using synchrotron X-ray microtomography in phase retrieval mode. Scientific Reports. 8(1). 14003–14003. 27 indexed citations
5.
Saigí, Maria, Anne McLeer‐Florin, Eva Pros, et al.. (2017). Genetic screening and molecular characterization of MET alterations in non-small cell lung cancer. Clinical & Translational Oncology. 20(7). 881–888. 15 indexed citations
6.
McLeer‐Florin, Anne, M. Duruisseaux, J. Pinsolle, et al.. (2017). ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer. Lung Cancer. 116. 15–24. 44 indexed citations
7.
Galateau-Sallé, Françoise, Anne McLeer‐Florin, Nolwenn Le Stang, et al.. (2016). Immune biomarkers PD-1/PD-L1 and TLR3 in malignant pleural mesotheliomas. Human Pathology. 52. 9–18. 61 indexed citations
8.
Duruisseaux, M., Anne McLeer‐Florin, Martine Antoine, et al.. (2016). NRG1 fusion in a French cohort of invasive mucinous lung adenocarcinoma. Cancer Medicine. 5(12). 3579–3585. 23 indexed citations
9.
Lantuéjoul, Sylvie, Isabelle Rouquette, Hélène Blons, et al.. (2015). French multicentric validation ofALKrearrangement diagnostic in 547 lung adenocarcinomas. European Respiratory Journal. 46(1). 207–218. 42 indexed citations
10.
Bavieri, Mario, et al.. (2014). Fishing for ALK with immunohistochemistry may predict response to crizotinib.. PubMed. 99(5). e229–32. 5 indexed citations
11.
Ferretti, G., Benoît Busser, Florence de Fraipont, et al.. (2013). Adequacy of CT-guided biopsies with histomolecular subtyping of pulmonary adenocarcinomas: Influence of ATS/ERS/IASLC guidelines. Lung Cancer. 82(1). 69–75. 36 indexed citations
12.
Mescam-Mancini, Lénaïg, Sylvie Lantuéjoul, Denis Moro‐Sibilot, et al.. (2013). On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas. Lung Cancer. 83(2). 168–173. 98 indexed citations
13.
Bavieri, Mario, Marcello Tiseo, Sylvie Lantuéjoul, et al.. (2013). Fishing for ALK with immunohistochemistry may predict response to crizotinib. Tumori Journal. 99(5). e229–e232. 6 indexed citations
14.
McLeer‐Florin, Anne & Sylvie Lantuéjoul. (2012). Why technical aspects rather than biology explain cellular heterogeneity in ALK-positive non-small cell lung cancer.. PubMed. 4(3). 240–1. 14 indexed citations
15.
McLeer‐Florin, Anne, Denis Moro‐Sibilot, Dimitri Salameire, et al.. (2011). Dual IHC and FISH Testing for ALK Gene Rearrangement in Lung Adenocarcinomas in a Routine Practice: A French Study. Journal of Thoracic Oncology. 7(2). 348–354. 151 indexed citations
16.
Combes, Sébastien, Pascale Barbier, Anne McLeer‐Florin, et al.. (2011). Synthesis and Biological Evaluation of 4-Arylcoumarin Analogues of Combretastatins. Part 2. Journal of Medicinal Chemistry. 54(9). 3153–3162. 103 indexed citations
17.
Boumendjel, Ahcène, Anne McLeer‐Florin, Pierre Champelovier, et al.. (2009). A novel chalcone derivative which acts as a microtubule depolymerising agent and an inhibitor of P-gp and BCRP in in-vitro and in-vivoglioblastoma models. BMC Cancer. 9(1). 242–242. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026